Conference Reports for NATAP
The Liver Meeting
San Francisco
November 2018
Back
 
Risk of Cardiovascular Disease Events after HCV Treatment: Results from ERCHIVES
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF